- 8-12 weeks treatment course
- Minimal recovery; normal activities throughout treatment
- 95%
China versus the U.S.
- China clinical rate
- $1,000 – $5,000
- $3,000
- United States
- $25,000 – $90,000
- $57,500
- You save
- ~95%
- $54,500 per procedure
Prices are approximate ranges. Actual cost depends on hospital, surgeon, materials, and case complexity.
What the procedure involves.
Direct-acting antiviral (DAA) therapy program achieving over 95% cure rates for hepatitis C, offered at major infectious disease hospitals in China. Treatment courses are significantly more affordable than in Western countries while using the same WHO-recommended medication regimens. Most patients achieve sustained virological response within 8-12 weeks of treatment.
Step by step.
Genotype Testing
HCV RNA quantification and genotype identification to determine optimal DAA combination
Pre-Treatment Assessment
Liver function evaluation, fibrosis staging, and drug interaction screening
DAA Therapy Course
Daily oral medication regimen with sofosbuvir-based combinations tailored to genotype
Sustained Virological Response Check
Confirmatory testing at 12 weeks post-treatment to verify viral clearance and cure
- Over 95% cure rate with modern DAA therapy
- Dramatic cost savings compared to US pricing
- Short treatment duration with minimal side effects
- Oral medications with no injections required
- Mild fatigue or headache during treatment
- Drug interactions with certain medications
- Rare treatment failure requiring retreatment
- Need for liver monitoring if advanced fibrosis present
Ask the AI for hospitals that handle hepatitis c cure program.
Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.